Sequana Medical NV
XBRU:SEQUA

Watchlist Manager
Sequana Medical NV Logo
Sequana Medical NV
XBRU:SEQUA
Watchlist
Price: 0.689 EUR -6.13% Market Closed
Market Cap: 46.9m EUR

Wall Street
Price Targets

SEQUA Price Targets Summary
Sequana Medical NV

Wall Street analysts forecast SEQUA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SEQUA is 2.788 EUR with a low forecast of 1.515 EUR and a high forecast of 4.2 EUR.

Lowest
Price Target
1.515 EUR
120% Upside
Average
Price Target
2.788 EUR
305% Upside
Highest
Price Target
4.2 EUR
510% Upside
Sequana Medical NV Competitors:
Price Targets
NXTMH
Nexstim Oyj
10% Downside
STE
STERIS plc
13% Upside
SENS
Senseonics Holdings Inc
184% Upside
ISRG
Intuitive Surgical Inc
10% Upside
NMTC
Neuroone Medical Technologies Corp
243% Upside
LUCD
Lucid Diagnostics Inc
245% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
9% Upside
PRM
Prim SA
24% Upside

Revenue
Forecast

Revenue Estimate
Sequana Medical NV

For the last 8 years the compound annual growth rate for Sequana Medical NV's revenue is -28%. The projected CAGR for the next 3 years is 462%.

-28%
Past Growth
462%
Estimated Growth
Estimates Accuracy
-16%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sequana Medical NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Sequana Medical NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SEQUA's stock price target?
Price Target
2.788 EUR

According to Wall Street analysts, the average 1-year price target for SEQUA is 2.788 EUR with a low forecast of 1.515 EUR and a high forecast of 4.2 EUR.

What is Sequana Medical NV's Revenue forecast?
Projected CAGR
462%

For the last 8 years the compound annual growth rate for Sequana Medical NV's revenue is -28%. The projected CAGR for the next 3 years is 462%.

Back to Top